The production of inflammatory proteins by the innate immune system is a tightly orchestrated procedure that allows the body to efficiently respond to exogenous and endogenous threats. Recently, accumulating evidence has indicated that disturbances in the inflammatory response system not only provoke autoimmune disorders, but also can have deleterious effects on neuronal function and mental health. As inflammation in the brain is primarily mediated by microglia, there has been an expanding focus on the mechanisms through which these cells initiate and propagate neuroinflammation. Microglia can enter persistently active states upon their initial recognition of an environmental stressor and are thereafter prone to elicit amplified and persistent inflammatory responses following subsequent exposures to stressors. A recent focus on why primed microglia cells are susceptible to environmental insults has been the NLRP3 inflammasome. Its function within the innate immune system is regulated in such a manner that supports a role for the complex in gating neuroinflammatory responses. The activation of NLRP3 inflammasome in microglia results in the cleavage of zymogen inflammatory interleukins into functional forms that elicit a number of consequential effects in the local neuronal environment. There is evidence to support the principle that within primed neuroimmune systems a lowered threshold for NLRP3 activation can cause persistent neuroinflammation or the amplified production of inflammatory cytokines, such as IL-1β and IL-18. Over the course of an individual's lifetime, persistent neuroinflammation can subsequently lead to the pathophysiological signatures that define psychological disorders. Therefore, targeting the NLRP3 inflammasome complex may represent an innovative and consequential approach to limit neuroinflammatory states in psychiatric disorders, such as major depressive disorder.
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Introduction
The ability to prepare and strengthen a response against threats -to be primed -is a principle readily adopted throughout our immune systems. A primed immune system aims to rapidly eliminate toxins or respond to environmental insults by lowering the kinetic threshold and the time needed to produce immunological responses. This ability is apparent within the adaptive immune system in how initial exposures to viral antigens prime the immune system to quickly and effectively eliminate viruses by immune cells, a feature we have leveraged to abolish once deadly viruses (Resik et al., 2013) . Meanwhile, through an evolutionarily conserved mechanism that involves non-antigen specific recognition by pathogen recognition receptors (PRRs), the innate immune system has also exhibited the capacity to become primed (Perry and Holmes, 2014) . However, as a consequence of decreased response thresholds primed immune systems are susceptible to spontaneous inflammatory bursts or persistent inflammation. The consequences of persistent inflammation or hypersensitive immune systems may compound over an individual's lifetime to alter homeostatic mechanisms and generate symptomatic pathologies. When this phenomenon occurs in the brain it will lead to decreased cognitive function and neural plasticity. In order to protect the brain a tightly regulated system would be required that is able to provide proper immune protection while buffering against persistent inflammation. Therefore, this review will focus on the NLRP3 inflammasome, a unique multiprotein complex that has recently been shown to play a central role in orchestrating the initiation and amplification of neuroinflammatory responses in primed neuroimmune cells, while increased activity of this complex is associated with heightened neuroinflammation. This review will also discuss the potential therapeutic approaches that target the NLRP3 inflammasome, and that may attenuate neuroinflammation and heightened immune activity observed in patients with a number of 
